GlassScriptPhysician profile
Renna Clark
NPI 1992428361
$1,491.68
in general payments reported to CMS, 2019-2025
21 companies · $741 in 2025
The $741 reported for 2025 was more than what 93% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.65 · 2023: $251 · 2024: $430 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214 · Education: $184 · Entertainment: $22.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.40 |
| Education | $183.99 |
| Entertainment | $22.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $505.84 | 2023-2025 | Veozah |
| Novo Nordisk INC | $135.61 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Sumitomo Pharma America, INC. | $121.85 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $79.23 | 2023-2024 | |
| Organon LLC | $67.89 | 2022-2025 | Nexplanon, Nuvaring |
| Pfizer INC. | $59.13 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $57.75 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mayne Pharma Commercial LLC | $57.25 | 2022-2023 | |
| Exact Sciences Corporation | $55.29 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $42.24 | 2025 | |
| Abbott Laboratories | $40.67 | 2025 | Freestyle Libre 3 |
| Biogen, INC. | $39.84 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $38.34 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Provepharm INC. | $36.33 | 2024-2025 | Bludigo |
| Boston Scientific Corporation | $28.53 | 2024 | Upsylon |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $24.96 | 2023 | Slynd |
| Smith+Nephew, INC. | $24.20 | 2025 | Pico 14 |
| Myovant Sciences INC. | $21.97 | 2022 | |
| Amgen INC. | $20.97 | 2025 | Evenity |
| Mycovia Pharmaceuticals, INC. | $18.81 | 2023 | Vivjoa |
| Otsuka America Pharmaceutical, INC. | $14.98 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renna Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.